Sab Biotherapeutics, Inc. · NASDAQ:SABS

Perceptive Advisors LLC reported a 7.30% stake in Sab Biotherapeutics, Inc. (Schedule 13G)

Event Jan 14, 2026 · Filed Jan 22, 2026

Perceptive Advisors LLC reported a 7.30% stake in Sab Biotherapeutics, Inc., 3,471,861 shares, as a passive investor on Jan 14, 2026. Filed Jan 22, 2026 (Schedule 13G).

Stake
7.30%
Shares
3,471,861
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC7.30%3,471,861
Joseph Edelman7.30%3,471,861
Perceptive Life Sciences Master Fund, Ltd.7.30%3,471,861

Source

View original at SEC

Related